ARGX
Argenx SE
Commercial-stage biopharmaceutical company developing antibody therapies for autoimmune diseases
ADRUnderlying: ARGXCUSIP: 04016X101HealthcareNL1 holder
Sponsored American Depositary Receipt (ADR) representing ordinary shares of argenx SE
Recent Activity
2021Q2
1 sell
-546.3K shares
-546.3K shares
Loading more activity...